Moreover, the co‐expression of ITGB3BP and cyclin‐dependent kinase inhibitor 2A (CDKN2A) is very common in human solid tumours, particularly in bladder cancer.21 The gene discussed is CDKN2A; the disease is urinary bladder carcinoma.